Skip to main content
. 2022 Jun 29;157(9):757–764. doi: 10.1001/jamasurg.2022.2235

Table 1. Patient Clinical and Procedural Characteristicsa.

Characteristic Participants, No. (%) P value
Plasma (n = 49) PCC (n = 51)
Age at surgery, median (IQR), y 69 (59-75) 70 (62-78) .44
Female 14 (28.6) 25 (49.0) .04
Male 35 (71.4) 26 (51.0)
BMI, median (IQR) 28.9 (25.9-32.8) 28.7 (24.4-32.6) .44
Medical history
Cerebrovascular accident 1 (2.0) 1 (2.0) >.99
Vascular thromboembolic disease 0 0 NA
Atrial fibrillation 0 6 (11.8) .03
eGFR <60 mL/min/1.73 m2 2 (4.1) 0 .24
Prior sternotomy 27 (55.1) 28 (54.9) >.99
Procedure performed
Aortic replacement 6 (12.2) 8 (15.7) .50
Multivalve repair or replacement 15 (30.6) 10 (19.6)
Valve repair or replacement plus CABG 8 (16.3) 13 (25.5)
Single valve 6 (12.2) 8 (15.7)
Aortic replacement plus valve repair or replacement 11 (22.4) 10 (19.6)
Aortic replacement plus CABG 0 1 (2.0)
Congenital defect repair 1 (2.0) 0
Pericardiectomy 2 (4.1) 0
CABG 0 1 (2.0)
Deep hypothermic circulatory arrest 11 (22.4) 16 (31.4) .37
Intraoperative antifibrinolytic 49 (100) 51 (100) NA
CPB time, median (IQR), min 155 (120-203) 161 (116-215) .94
Any cross-clamp use 44 (89.8) 47 (92.2) .74
Cross-clamp time, median (IQR), minb 117 (85-165) 114 (84-158) .77

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; eGFR, estmated glomerular filtration rate; NA, not applicable; PCC, prothrombin complex concentrate.

a

Continuous variables are summarized using median (IQR) and compared between groups using the rank sum test. Categorical variables are summarized using No. (%) and compared between groups using the Fisher exact test.

b

Cross-clamp time is summarized for patients who required cross-clamp use (n = 44 and n = 47 for the plasma and PCC groups, respectively).